NABRIVA THERAPEUTICS PLC's ticker is and the CUSIP is G63637105. A total of 3 filers reported holding NABRIVA THERAPEUTICS PLC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $16,000 | -87.8% | 30,433 | -86.6% | 0.00% | – |
| Q1 2020 | $131,000 | -90.8% | 227,565 | -78.9% | 0.00% | -100.0% |
| Q4 2019 | $1,425,000 | -48.4% | 1,079,665 | -21.7% | 0.00% | -50.0% |
| Q3 2019 | $2,759,000 | -12.6% | 1,379,265 | +6.1% | 0.00% | -33.3% |
| Q2 2019 | $3,157,000 | +51.2% | 1,299,365 | +51.8% | 0.00% | +50.0% |
| Q1 2019 | $2,088,000 | +169.8% | 855,765 | +61.4% | 0.00% | +100.0% |
| Q4 2018 | $774,000 | +0.5% | 530,165 | +85.8% | 0.00% | 0.0% |
| Q3 2018 | $770,000 | +299.0% | 285,300 | +576.1% | 0.00% | – |
| Q2 2018 | $193,000 | +30.4% | 42,200 | +43.5% | 0.00% | – |
| Q1 2018 | $148,000 | -86.4% | 29,400 | -83.9% | 0.00% | -100.0% |
| Q4 2017 | $1,091,000 | – | 182,398 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| FRAZIER MANAGEMENT LLC | 4,256,526 | $11,493,000 | 2.10% |
| Vivo Capital, LLC | 6,619,190 | $17,872,000 | 1.80% |
| Novo Holdings A/S | 4,703,720 | $12,700,000 | 1.01% |
| Rock Springs Capital Management LP | 1,800,000 | $4,860,000 | 0.18% |
| Orbimed Advisors | 4,644,600 | $12,540,000 | 0.15% |
| Clear Harbor Asset Management, LLC | 212,500 | $443,000 | 0.09% |
| Granahan Investment Management | 247,276 | $668,000 | 0.04% |
| WEDBUSH SECURITIES INC | 92,050 | $249,000 | 0.03% |
| Laurion Capital Management LP | 419,670 | $1,133,000 | 0.01% |
| SECTORAL ASSET MANAGEMENT INC | 38,255 | $103,000 | 0.01% |